References
- Wagner H. N., Jr., et al. New Eng. J. Med. 1964; 271: 377
- Lee T.K., Sokolosk T.D., Royer G.P. Science 1981; 213: 233
- Kramer P.A. J. Pharm. Sci. 1974; 63: 1646
- Kim C.K., et al. Arch. Pharm. Res. 1985; 8: 159
- Widder K.J., et al. Eur. J. Cancer Clin. Oncol. 1983; 19(1)141
- Kramer P.A., Burnstein T. Life Sci. 1976; 19: 515
- Morimoto Y., et al. Chem. Pharm. Bull. 1930; 28: 3087
- Morimoto Y., Sugibayashi K., Kato Y. Chem. Pharm. Bull. 1981; 29: 1433
- Zolle I., Rhodes B.A., Wagner H. N., Jr. Int. J. Appl. Rad. Iso. 1970; 21: 155
- Cornell R.P., Saba T.M. Am. J. Physiol. 1973; 225: 1300
- Scheffel U., Rhodes B.A., Natrajan J.K., Wagner H. N., Jr. J. Nucl. Med. 1987; 13: 498
- Ishizaka T., Endo K., Koishi M. J. Pharm. Sci. 1981; 70: 358
- Senyei A.E., et al. J. Pharm. Sci. 1981; 70: 38
- Yapel A.F. 1935; 3, Methods Enzymol., 112 Drug enzyme targeting, Pt. A
- Kim C.K., Lee J.K., Lah W.L. Arch. Pharm. Res. 1986; 9: 39
- Willmott N., Cummings J., Stuart J.F.B., Florence A.T. Biopharm. and Drug Disp. 1985; 6: 91